Shanghai Pharmaceuticals Holding Co., Ltd
601607
Xếp hạng trong cổ phiếu
#2386
Shanghai Pharmaceuticals Holding Co., Ltd., a diversified investment holding... Shanghai Pharmaceuticals Holding Co., Ltd., a diversified investment holding entity established in 1994 and headquartered in Shanghai, China, plays a crucial role in the People's Republic of China's pharmaceutical and healthcare sectors. As a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd., its extensive operations encompass research, development, manufacturing, distribution, and retail of a wide array of products. The company's business model is structured around four principal segments: Production, Distribution, Retail, and an 'Others' category. Within its Production segment, it develops and manufactures a broad portfolio of pharmaceuticals, including chemical and biochemical drugs, traditional Chinese medicines, healthcare solutions, and medical devices. These offerings target diverse therapeutic fields such as oncology, cardiovascular and cerebrovascular conditions, central nervous system disorders, general infections, immunological diseases, digestive and metabolic ailments, and respiratory issues. The company's product range comprises approximately 700 distinct drug varieties. Beyond manufacturing, its Distribution arm is instrumental in providing comprehensive pharmaceutical supply chain solutions. This includes warehousing, logistics, and value-added services for various industry players, from pharmaceutical manufacturers to dispensers like hospitals, other distributors, and retail pharmacies. Furthermore, the company manages an extensive network of retail pharmacies, alongside a burgeoning online drug sales platform. This retail footprint spans approximately 2,000 chain pharmacies across 24 provinces. Its 'Others' segment encompasses a variety of support and innovative services, such as consulting, asset management, clinical trial coordination, medical assistance programs, educational initiatives for healthcare professionals and patients, e-prescription management systems, and the development of remote and cloud hospital technologies.
Giá cổ phiếu
$2.43
Vốn hóa thị trường
$8.09B
Thay đổi (1 ngày)
-1.16%
Thay đổi (1 năm)
-5.94%
Quốc gia
CN
Giao dịch Shanghai Pharmaceuticals Holding Co., Ltd (601607)
Danh mục
Healthcare
Lịch sử lợi suất cổ tức của Shanghai Pharmaceuticals Holding Co., Ltd (601607)
Lợi suất cổ tức (TTM) của Shanghai Pharmaceuticals Holding Co., Ltd (mã cổ phiếu: 601607) tại thời điểm 2024-12-31 là: 4.63%
Lợi suất cổ tức trung bình trong 5 năm qua: 4.04%
Lợi suất cổ tức trung bình trong 5 năm qua: 4.04%
Lịch sử lợi suất cổ tức của Shanghai Pharmaceuticals Holding Co., Ltd (601607) từ 2001 đến 2026
Lợi suất cổ tức vào cuối mỗi năm (TTM)
| Năm | Lợi suất cổ tức | Thay đổi |
|---|---|---|
| 2026 (TTM) | 3.52% | -16.78% |
| 2025 | 4.23% | -8.64% |
| 2024 | 4.63% | -28.11% |
| 2023 | 6.44% | 157.60% |
| 2022 | 2.50% | 3.31% |
| 2021 | 2.42% | 5.68% |
| 2020 | 2.29% | 2.69% |
| 2019 | 2.23% | -56.10% |
| 2018 | 5.08% | 89.55% |
| 2017 | 2.68% | -2.19% |
| 2016 | 2.74% | 6.61% |
| 2015 | 2.57% | -8.87% |
| 2014 | 2.82% | 6.42% |
| 2013 | 2.65% | -11.37% |
| 2012 | 2.99% | 3.46% |
| 2011 | 2.89% | 131.20% |
| 2010 | 1.25% | 155.10% |
| 2009 | 0.49% | -89.75% |
| 2008 | 4.78% | 177.91% |
| 2007 | 1.72% | -65.81% |
| 2006 | 5.03% | -61.98% |
| 2005 | 13.23% | 104.48% |
| 2004 | 6.47% | 23.95% |
| 2003 | 5.22% | 44.20% |
| 2002 | 3.62% | 153.15% |
| 2001 | 1.43% | 0.00% |
Lợi suất cổ tức (TTM) của các công ty tương tự hoặc đối thủ
| Công ty | Lợi suất cổ tức | Quốc gia |
|---|---|---|
| 0.35% |
US
|
|
| 0.00% |
US
|
|
| 0.83% |
US
|
|
| 0.00% |
US
|
|
| 1.42% |
AU
|
